Cargando…

Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents

BACKGROUND: There are currently 7 known serotypes of botulinum neurotoxin (BoNT) classified upon non-cross reactivity of neutralizing immunoglobulins. Non-neutralizing immunoglobulins, however, can exhibit cross-reactivities between 2 or more serotypes, particularly mosaic forms, which can hamper th...

Descripción completa

Detalles Bibliográficos
Autores principales: Conway, Jerry O., Sherwood, Laura J., Collazo, M. Thelma, Garza, John A., Hayhurst, Andrew
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809108/
https://www.ncbi.nlm.nih.gov/pubmed/20098614
http://dx.doi.org/10.1371/journal.pone.0008818
_version_ 1782176589809713152
author Conway, Jerry O.
Sherwood, Laura J.
Collazo, M. Thelma
Garza, John A.
Hayhurst, Andrew
author_facet Conway, Jerry O.
Sherwood, Laura J.
Collazo, M. Thelma
Garza, John A.
Hayhurst, Andrew
author_sort Conway, Jerry O.
collection PubMed
description BACKGROUND: There are currently 7 known serotypes of botulinum neurotoxin (BoNT) classified upon non-cross reactivity of neutralizing immunoglobulins. Non-neutralizing immunoglobulins, however, can exhibit cross-reactivities between 2 or more serotypes, particularly mosaic forms, which can hamper the development of highly specific immunoassays, especially if based on polyclonal antisera. Here we employ facile recombinant antibody technology to subtractively select ligands to each of the 7 BoNT serotypes, resulting in populations with very high specificity for their intended serotype. METHODS AND FINDINGS: A single llama was immunized with a cocktail of 7 BoNT toxoids to generate a phage display library of single domain antibodies (sdAb, VHH or nanobodies) which were selected on live toxins. Resulting sdAb were capable of detecting both toxin and toxin complex with the best combinations able to detect 100s-10s of pg per 50 µL sample in a liquid bead array. The most sensitive sdAb were combined in a heptaplex assay to identify each of the BoNT serotypes in buffer and milk and to a lesser extent in carrot juice, orange juice and cola. Several anti-A(1) sdAb recognized A2 complex, showing that subtype cross-reactivity within a serotype was evident. Many of our sdAb could act as both captor and tracer for several toxin and toxin complexes suggesting sdAb can be used as architectural probes to indicate BoNT oligomerisation. Six of 14 anti-A clones exhibited inhibition of SNAP-25 cleavage in the neuro-2A assay indicating some sdAb had toxin neutralizing capabilities. Many sdAb were also shown to be refoldable after exposure to high temperatures in contrast to polyclonal antisera, as monitored by circular dichroism. CONCLUSIONS: Our panel of molecularly flexible antibodies should not only serve as a good starting point for ruggedizing assays and inhibitors, but enable the intricate architectures of BoNT toxins and complexes to be probed more extensively.
format Text
id pubmed-2809108
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-28091082010-01-23 Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents Conway, Jerry O. Sherwood, Laura J. Collazo, M. Thelma Garza, John A. Hayhurst, Andrew PLoS One Research Article BACKGROUND: There are currently 7 known serotypes of botulinum neurotoxin (BoNT) classified upon non-cross reactivity of neutralizing immunoglobulins. Non-neutralizing immunoglobulins, however, can exhibit cross-reactivities between 2 or more serotypes, particularly mosaic forms, which can hamper the development of highly specific immunoassays, especially if based on polyclonal antisera. Here we employ facile recombinant antibody technology to subtractively select ligands to each of the 7 BoNT serotypes, resulting in populations with very high specificity for their intended serotype. METHODS AND FINDINGS: A single llama was immunized with a cocktail of 7 BoNT toxoids to generate a phage display library of single domain antibodies (sdAb, VHH or nanobodies) which were selected on live toxins. Resulting sdAb were capable of detecting both toxin and toxin complex with the best combinations able to detect 100s-10s of pg per 50 µL sample in a liquid bead array. The most sensitive sdAb were combined in a heptaplex assay to identify each of the BoNT serotypes in buffer and milk and to a lesser extent in carrot juice, orange juice and cola. Several anti-A(1) sdAb recognized A2 complex, showing that subtype cross-reactivity within a serotype was evident. Many of our sdAb could act as both captor and tracer for several toxin and toxin complexes suggesting sdAb can be used as architectural probes to indicate BoNT oligomerisation. Six of 14 anti-A clones exhibited inhibition of SNAP-25 cleavage in the neuro-2A assay indicating some sdAb had toxin neutralizing capabilities. Many sdAb were also shown to be refoldable after exposure to high temperatures in contrast to polyclonal antisera, as monitored by circular dichroism. CONCLUSIONS: Our panel of molecularly flexible antibodies should not only serve as a good starting point for ruggedizing assays and inhibitors, but enable the intricate architectures of BoNT toxins and complexes to be probed more extensively. Public Library of Science 2010-01-21 /pmc/articles/PMC2809108/ /pubmed/20098614 http://dx.doi.org/10.1371/journal.pone.0008818 Text en Conway et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Conway, Jerry O.
Sherwood, Laura J.
Collazo, M. Thelma
Garza, John A.
Hayhurst, Andrew
Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents
title Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents
title_full Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents
title_fullStr Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents
title_full_unstemmed Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents
title_short Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents
title_sort llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809108/
https://www.ncbi.nlm.nih.gov/pubmed/20098614
http://dx.doi.org/10.1371/journal.pone.0008818
work_keys_str_mv AT conwayjerryo llamasingledomainantibodiesspecificforthe7botulinumneurotoxinserotypesasheptapleximmunoreagents
AT sherwoodlauraj llamasingledomainantibodiesspecificforthe7botulinumneurotoxinserotypesasheptapleximmunoreagents
AT collazomthelma llamasingledomainantibodiesspecificforthe7botulinumneurotoxinserotypesasheptapleximmunoreagents
AT garzajohna llamasingledomainantibodiesspecificforthe7botulinumneurotoxinserotypesasheptapleximmunoreagents
AT hayhurstandrew llamasingledomainantibodiesspecificforthe7botulinumneurotoxinserotypesasheptapleximmunoreagents